American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 41-50 , January 2009

Randomized Placebo-Controlled Trial Assessing a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Plasma Asymmetric Dimethylarginine Concentration in Mild to Moderate CKD

  • Prabath W.B. Nanayakkara, MD

      Affiliations

    • Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands
    • Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationAddress correspondence to Prabath W.B. Nanayakkara, MD, Department of Internal Medicine, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    • ,
  • Jessica C. Kiefte-de Jong, MSc

      Affiliations

    • Institute of Health Sciences, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands
    • ,
  • Piet M. ter Wee, MD, PhD

      Affiliations

    • Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
    • Department of Nephrology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Coen D.A. Stehouwer, MD, PhD

      Affiliations

    • Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands
    • ,
  • Frans J. van Ittersum, MD, PhD

      Affiliations

    • Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
    • Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands
    • ,
  • Margreet R. Olthof, MSc, PhD

      Affiliations

    • Institute of Health Sciences, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands
    • ,
  • Tom Teerlink, MD, PhD

      Affiliations

    • Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
    • Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Jos W.R. Twisk, MD, PhD

      Affiliations

    • Institute for Research in Extramural Medicine, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Coen van Guldener, MD, PhD

      Affiliations

    • Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands
    • ,
  • Yvo M. Smulders, MD, PhD

      Affiliations

    • Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands
    • Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands

Received 24 February 2008 ,Accepted 9 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2008.06.016 on September 16, 2008.

 Trial registration: http://clinicaltrials.gov; study number: NCT00384618.

PII: S0272-6386(08)01101-3

doi: 10.1053/j.ajkd.2008.06.016

American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 41-50 , January 2009

Article Tools

* Image Usage & Resolution